{"nct_id":"NCT03476239","title":"Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2017-10-18","start_date_type":"ACTUAL","primary_completion_date":"2019-08-21","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}